Li Xiaoqiang, Guo Kaimin, Zhang Ruili, Wang Wenjia, Sun He, Yagüe Ernesto, Hu Yunhui
Cloudphar Pharmaceuticals Co., Ltd., Shenzhen, China.
College of Pharmacy, Haihe Education Park, Nankai University, Tianjin, China.
Front Pharmacol. 2022 May 25;13:894427. doi: 10.3389/fphar.2022.894427. eCollection 2022.
Ischemic stroke (IS) is an acute neurological injury that occurs when a vessel supplying blood to the brain is obstructed, which is a leading cause of death and disability. S has been used in the treatment of cardiovascular and cerebrovascular diseases for over thousands of years due to its effect activating blood circulation and dissipating blood stasis. However, the herbal preparation is chemically complex and the diversity of potential targets makes difficult to determine its mechanism of action. To gain insight into its mechanism of action, we analyzed "Salvianolic acid for injection" (SAFI), a traditional Chinese herbal medicine with anti-IS effects, using computational systems pharmacology. The potential targets of SAFI, obtained from literature mining and database searches, were compared with IS-associated genes, giving 38 common genes that were related with pathways involved in inflammatory response. This suggests that SAFI might function as an anti-inflammatory agent. Two genes associated with inflammation ( and ), which were inhibited by SAFI, were preliminarily validated . The results showed that SAFI inhibited PTGS1 and PTGS2 activity in a dose-dependent manner and inhibited the production of prostaglandin E2 induced by lipopolysaccharide in RAW264.7 macrophages and BV-2 microglia. This approach reveals the possible pharmacological mechanism of SAFI acting on IS, and also provides a feasible way to elucidate the mechanism of traditional Chinese medicine (TCM).
缺血性中风(IS)是一种急性神经损伤,当供应大脑血液的血管受阻时就会发生,这是导致死亡和残疾的主要原因。由于其活血化瘀的作用,S已被用于治疗心脑血管疾病达数千年之久。然而,这种草药制剂化学成分复杂,潜在靶点的多样性使得难以确定其作用机制。为了深入了解其作用机制,我们使用计算系统药理学分析了具有抗IS作用的传统中药“注射用丹参酚酸”(SAFI)。通过文献挖掘和数据库搜索获得的SAFI潜在靶点与IS相关基因进行比较,得到38个与炎症反应相关途径有关的共同基因。这表明SAFI可能作为一种抗炎剂发挥作用。初步验证了SAFI抑制的两个与炎症相关的基因(和)。结果表明,SAFI以剂量依赖的方式抑制PTGS1和PTGS2活性,并抑制RAW264.7巨噬细胞和BV-2小胶质细胞中脂多糖诱导的前列腺素E2的产生。这种方法揭示了SAFI作用于IS的可能药理机制,也为阐明中药作用机制提供了一种可行的方法。